Jason Poston's peptide content: what the science actually supports
Quick answer
Poston describes a current protocol combining physician-supervised TRT, Anavar (oxandrolone), and multiple peptides, contrasting it with his prior heavy anabolic steroid use during professional bodybuilding competition. While TRT with medical oversight and regular bloodwork monitoring represents standard practice for documented hypogonadism, the addition of oxandrolone means this is not a peptide-only protocol, and the long-term cardiovascular and endocrine risks of ongoing anabolic steroid use are not eliminated by short-term lab results. Most peptides referenced in this category lack completed human RCTs supporting the physique and longevity outcomes being implied.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @jasonposton_ actually say?
Poston's core argument is that his current physique, built on "doctor prescribed peptides" and TRT, is comparable to his competitive bodybuilding years when he was using anabolic steroids including trenbolone. He frames this as a sustainability story: the steroid look "is not sustainable" for longevity, while his current protocol, which he says includes Anavar alongside TRT, gives him a physique he loves with great bloodwork. He also takes a shot at Liver King, pointing out the $11,000 monthly supplement spend while implying his own medically supervised approach is the more honest path.
Worth noting: he is not claiming to be natural. He explicitly lists Anavar and TRT on top of the peptides. That transparency matters, and it changes how we should read the "clinical grade" framing he's leaning into throughout.
Does the science back this up?
The short answer is: partially, and with important caveats. TRT at physiological doses is one of the better-studied interventions in men's health, with documented benefits for body composition, mood, and metabolic markers when properly managed. Peptides are a different story. The evidence base is thin, fragmented, and mostly preclinical.
Growth hormone secretagogues like CJC-1295 and ipamorelin, which are common in these protocols, have shown modest effects on GH pulse amplitude in small trials (Ionescu and Frohman, 2006, Journal of Clinical Endocrinology and Metabolism), but long-term human data on body composition outcomes is sparse. BPC-157 has compelling rodent data on tissue repair but zero completed human RCTs as of 2024. GHK-Cu shows interesting wound-healing properties in vitro but human clinical evidence is limited. The honest summary is that most peptides being sold as longevity tools are operating well ahead of their evidence base.
Anavar (oxandrolone) is a Schedule III anabolic steroid. Calling a stack that includes Anavar a "clinical grade" protocol is a stretch. It has legitimate medical uses, but the framing softens what is still a steroid cycle.
What did they get wrong (or right)?
He gets credit for being upfront. Admitting trenbolone use, naming Anavar, disclosing TRT, and calling out Liver King's dishonesty are all moves in the right direction for a space full of bad-faith actors. That transparency is genuinely uncommon in fitness content.
Where he goes wrong is the implicit equivalence between "clinical grade" and safe or evidence-based. Anavar is not a peptide. Including it in the same breath as peptide therapy and then saying "my bloodwork is great" conflates two very different things. Short-term bloodwork looking clean does not rule out long-term consequences of ongoing anabolic steroid use, including cardiovascular remodeling. A 2017 study by Baggish et al. in Circulation found that long-term anabolic steroid users showed significantly impaired left ventricular function compared to non-users, even after cessation.
The "sustainable for longevity" claim applied to a protocol that still includes an oral anabolic steroid deserves scrutiny. He may look and feel great now. That does not make the protocol low-risk over a decade.
What should you actually know?
TRT under physician supervision with regular bloodwork is a legitimate, well-studied intervention for men with documented hypogonadism. That part of his protocol has real clinical backing. Peptide therapy is a more complicated picture: some peptides have real research interest behind them, but most are being used in clinical practice significantly ahead of human trial data.
Anavar is a controlled substance in the US. Compounded or prescribed oxandrolone exists for specific medical indications like muscle-wasting conditions, but using it as part of a physique optimization protocol is off-label and carries real risks that are not erased by a recent clean CBC. Cardiac, hepatic, and endocrine side effects are dose and duration dependent, and many take years to surface.
If you are considering any peptide protocol, the most useful thing Poston's video demonstrates is the value of physician oversight and regular labs. That part is real. But "my bloodwork is great" from someone seven years post-competitive bodybuilding, still on Anavar and TRT, is not a safety guarantee you should borrow for yourself.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Jason Poston's peptide content: what the science actually supports, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Multifunctionality and Possible Medical Application of the BPC 157 Peptide
Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.
PubMed
Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing
Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.
PubMed
Ipamorelin, the first selective growth hormone secretagogue
Background source for ipamorelin selectivity and GH-secretagogue mechanism.
PubMed
The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation
Preclinical context that should not be overstated as consumer clinical evidence.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Jason Poston's peptide content: what the science actually supports should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Helpful context before the funnel
Claim verdict
The useful answer behind this video
Claim being checked
Poston describes a current protocol combining physician-supervised TRT, Anavar (oxandrolone), and multiple peptides, contrasting it with his prior heavy anabolic steroid use during professional bodybuilding competition.
FormBlends verdict
Poston describes a current protocol combining physician-supervised TRT, Anavar (oxandrolone), and multiple peptides, contrasting it with his prior heavy anabolic steroid use during professional bodybuilding competition. While TRT with medical oversight and regular bloodwork monitoring represents standard practice for documented hypogonadism, the addition of oxandrolone means this is not a peptide-only protocol, and the long-term cardiovascular and endocrine risks of ongoing anabolic steroid use are not eliminated by short-term lab results. Most peptides referenced in this category lack completed human RCTs supporting the physique and longevity outcomes being implied.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Poston describes a current protocol combining physician-supervised TRT, Anavar (oxandrolone), and multiple peptides, contrasting it with his prior heavy anabolic steroid use during professional bodybuilding competition. While TRT with medical oversight and regular bloodwork monitoring represents standard practice for documented hypogonadism, the addition of oxandrolone means this is not a peptide-only protocol, and the long-term cardiovascular and endocrine risks of ongoing anabolic steroid use are not eliminated by short-term lab results. Most peptides referenced in this category lack completed human RCTs supporting the physique and longevity outcomes being implied.
- Anavar (oxandrolone) is a Schedule III anabolic steroid, not a peptide. Including it in a protocol does not make that protocol steroid-free, regardless of physician oversight.
- TRT under physician supervision with regular monitoring is one of the better-studied male hormone interventions, with documented effects on body composition and metabolic health when used for diagnosed hypogonadism.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Anavar (oxandrolone) is a Schedule III anabolic steroid, not a peptide. Including it in a protocol does not make that protocol steroid-free, regardless of physician oversight.
- TRT under physician supervision with regular monitoring is one of the better-studied male hormone interventions, with documented effects on body composition and metabolic health when used for diagnosed hypogonadism.
- A 2017 study by Baggish et al. in Circulation found persistent left ventricular dysfunction in long-term anabolic steroid users, including after stopping use, meaning clean short-term bloodwork does not rule out cardiac risk.
- Most peptides marketed for physique and longevity, including BPC-157 and GHK-Cu, lack completed human RCTs as of 2024. Preclinical rodent data and in vitro studies do not translate automatically to human outcomes.
- Growth hormone secretagogues like CJC-1295 and ipamorelin have shown GH pulse effects in small trials (Ionescu and Frohman, 2006, JCEM), but long-term human body composition and safety data remain limited.
- Transparency about what you are actually taking, as Poston demonstrates by naming Anavar and TRT directly, is meaningfully better practice than the natural claims common in fitness content, but transparency is not the same as safety evidence.
- Physician oversight and regular bloodwork are the most defensible parts of any hormone or peptide protocol. The specific compounds prescribed still need to be evaluated individually on their own evidence, not grouped under a single safety umbrella.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jason Poston · TikTok creator
39.4K views on this video
Jason Poston's peptide content: what the science actually supports
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Jason Poston, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.